Skip to main content
Nucleic Acids Research logoLink to Nucleic Acids Research
. 2025 Jul 30;53(14):gkaf715. doi: 10.1093/nar/gkaf715

A U3 snoRNA is required for the regulation of chromatin dynamics and antiviral response in Drosophila melanogaster

Shruti Jain 1, Jordi Planells 2, Isabel Regadas 3, Donal Barrett 4, Anne von Euler 5, Indranil Sinha 6, Bo Gustav Lindberg 7, Jenny C Hesson 8, Patrycja Swacha 9, Nelson O Gekara 10, Vicent Pelechano 11, Ylva Engström 12, Mattias Mannervik 13, Neus Visa 14,
PMCID: PMC12309367  PMID: 40737091

Abstract

Small nucleolar RNAs (snoRNAs) are prevailing components of the chromatin-associated transcriptome. Here we show that specific snoRNAs are required for the activation of immune response genes and for survival during viral infections in Drosophila melanogaster. We have studied snoRNA:U3:9B, a chromatin-associated snoRNA that binds to a large number of protein coding genes, including immune response genes. We have used CRISPR/Cas9 to delete snoRNA:U3:9B and study its function in vivo. SnoRNA:U3:9B-deficient larvae are viable but failed to develop into pupae when challenged by expression of a Sindbis virus replicon. SnoRNA:U3:9B is localized to immune genes in vivo and the chromatin decompaction and gene activation typically observed at immune genes following infection are abolished in snoRNA:U3:9B-deficient larvae, which suggests that this snoRNA acts locally to regulate chromatin accessibility. Mechanistically, snoRNA:U3:9B is required for the recruitment of the chromatin remodeler Brahma to a set of target immune genes. In summary, these results uncover an antiviral defense mechanism that relies on a snoRNA for the recruitment of a chromatin remodeling factor to immune genes to facilitate immune gene activation.

Graphical Abstract

Graphical Abstract.

Graphical Abstract

Introduction

Noncoding RNAs (ncRNAs) play important regulatory functions. Some ncRNAs are exported to the cytoplasm, but others can associate with the chromatin and regulate genome architecture and gene expression [1]. The study of the chromatin–RNA interactome has been boosted by the development of technologies for global profiling of chromatin-associated RNAs (caRNAs) [2–6]. These technologies have provided comprehensive descriptions of the chromatin-associated transcriptome and have revealed that small nucleolar RNAs (snoRNAs) constitute a relatively large caRNA component in both insect and mammalian cells [7, 8]. SnoRNAs are small ncRNAs with a length of 60–300 nt that are conserved among eukaryotes [9]. They associate with a set of proteins to form snoRNA–protein complexes (snoRNPs), and their canonical function is to guide site-specific modifications in a variety of target RNAs through interactions that rely on sequence complementarity [10–12]. The RNA targets of many snoRNAs have been either identified experimentally by methods developed for detection of RNA–RNA interactions [13–16] or predicted with the help of in silico approaches [17–19]. The fly and human genomes encode ∼250 and 750 snoRNA genes, respectively [20, 21].

SnoRNAs were initially discovered for their roles in the processing and modification of rRNAs, but they are also responsible for post-transcriptional modifications of other RNA species, including small nuclear RNAs (snRNAs), transfer RNAs, and messenger RNAs (mRNAs) [22–24]. From a structural perspective, snoRNAs can be classified into two main groups that are characterized by distinctive structural elements or boxes, specific sets of associated proteins, and the type of chemical modification they direct. The box C/D snoRNAs associate with the methyltransferase Fibrillarin and guide 2′-O-ribose methylation, while the box H/ACA snoRNAs interact with Dyskerin and direct pseudouridylation of their target RNAs [11]. Moreover, some snoRNAs such as the U3 snoRNAs act by promoting site-specific pre-ribosomal RNA (rRNA) cleavage rather than guiding nucleotide modifications [25].

In addition to their housekeeping functions in processing ribosomal RNA precursors, snoRNAs have been implicated in a variety of other cellular processes. These include mitotic progression, telomere maintenance, regulation of pre-mRNA splicing, and 3′ end processing [26–29]. Moreover, some snoRNAs are processed into miRNA-like molecules that can act like miRNAs [30] and others have regulatory functions. For example, snoRNPs activate PARP-1 in breast cancer cells, which enhances ribosome biogenesis and cell proliferation [31], and a small Cajal body-associated snoRNA regulates DNA repair by binding to the catalytic subunit of the DNA-dependent protein kinase DNA-PK [32]. SnoRNAs have also been involved in the regulation of chromatin compaction. Following a series of elegant in vitro experiments, Schubert et al. [33] showed that snoRNAs together with the histone binding protein Df31 can bind chromatin and relax higher-order chromatin structures in both human and insect cells. However, the extent of such regulation in vivo and its physiological significance remain largely unexplored.

Given their crucial roles in RNA biology, it is not surprising that snoRNAs are key players in human diseases, as demonstrated by research conducted over the past decade. For example, loss of the human SNORD116 gene has been directly linked to the Prader–Willi syndrome [34, 35], mutations in the U8 snoRNA cause Labrune syndrome, a neurological disorder that affects cerebral small blood vessels [36], and several other snoRNAs have been proposed to act as proto-oncogenes or tumor suppressors, which has sparked interest in snoRNAs as potential targets for diagnostics or therapeutic interventions [37–41]. Moreover, snoRNAs are often deregulated upon viral infection and many of them have been found to be involved in viral replication or virus-host interactions [42].

Drosophila melanogaster is a powerful model organism to study innate immune responses [43, 44]. The Drosophila antiviral defense includes cellular reactions and humoral responses that involve the production of antimicrobial peptides (AMPs) and other immune effectors. RNA interference is the major antiviral defense mechanism in insects and operates against a large diversity of viruses [45, 46]. In the RNA interference pathway, the ribonuclease Dicer-2 recognizes double-stranded RNAs of viral origin and cleaves them into small interfering RNAs that are loaded onto RISC complexes and enable RISC to degrade complementary viral sequences. Dicer-2 also induces the expression of Vago, a small antiviral peptide that activates the JAK-STAT pathway [47]. JAK-STAT, together with Toll, Imd, MAPK/JNK, and Hippo, are evolutionarily conserved signaling pathways that contribute to insect innate immunity in different ways [48, 49]. The Toll and Imd pathways, which are essential for the immune response to fungi and bacteria via the production of AMPs [50], also play a role in antiviral defence through mechanisms that remain poorly understood [51, 52]. The MAPK/JNK and Hippo pathways are involved in a variety of biological processes and contribute to the innate immune responses by modulating the expression of key Toll and Imd factors [53, 54]. Recent research has demonstrated that the coordinated action of various immune pathways is a critical feature of the antiviral response in Drosophila [55].

We have profiled caRNAs in Schneider 2 (S2) cells of D. melanogaster [56] and identified several snoRNAs, including snoRNA:U3:9B, that are enriched in the chromatin. Here we combine molecular biology and loss-of-function approaches to study the role of snoRNA:U3:9B. This snoRNA shares a high degree of sequence homology with two other U3 snoRNAs that play an essential role in pre-rRNA processing [57]. However, snoRNA:U3:9B contains a unique RNA sequence that is not present in the other U3 snoRNAs (Supplementary Fig. S1). SnoRNA:U3:9B is expressed at relatively low levels under normal growth conditions and genetic knock-out flies that lack the snoRNA:U3:9B gene are viable. The expression of snoRNA:U3:9B is significantly upregulated following infection with Sindbis virus and that deletion of the snoRNA:U3:9B gene is lethal in combination with Sindbis virus infection. While other snoRNAs are necessary for optimal viral replication, our results reveal that snoRNA:U3:9B is required for the activation of antiviral response genes through a mechanism that involves changes in chromatin accessibility.

Materials and methods

Culture of S2 cells

Drosophila melanogaster S2 cells were cultured at 28°C in Schneider’s medium (Gibco) supplemented with 10% fetal bovine serum (FBS; Gibco), 50 μg/ml streptomycin, and 50 U/ml penicillin (Gibco).

Total RNA and caRNA extractions

Total RNA was extracted using Trizol (Ambion) and ethanol-precipitated following standard procedures. Isolated RNA was quantified using NanoDrop One (Thermo Scientific). For caRNA extraction, S2 cells were crosslinked with formaldehyde for 10 min at room temperature (RT) and the cross-linking was stopped by addition of 1 M glycine for 10 additional min. The cells were then collected and resuspended in Buffer 1 [50 mM Hepes, pH 7.6, 140 mM NaCl, 1 mM ethylenediaminetetraacetic acid (EDTA), 10% glycerol, 0.5% NP-40, 0.25% Triton X-100, and cOmplete protease inhibitors] and incubated for 10 min at 4°C, followed by centrifugation at 4°C and 500 × g. The pellet was resuspended in cold Buffer 2 (200 mM NaCl, 1 mM EDTA, 0.5 mM ethyleneglycol tetraacetic acid (EGTA), 10 mM Tris, pH 8, and cOmplete protease inhibitors) and centrifuged again. Finally, chromatin was resuspended in Buffer 3 (1 mM EDTA, 0.5 mM EGTA, and 10 mM Tris, pH 8, and cOmplete protease inhibitors). Chromatin was fragmented using a Bioruptor sonicator (Diagenode) with 40 high intensity sonication 30 s on/off pulses. Protein concentration was measured using a NanoDrop One. The chromatin fraction was treated with DNAse I (Thermo Scientific) and Proteinase K (Thermo Scientific). RNA was isolated with Trizol (Ambion). RNA concentration was measured with NanoDrop.

Reverse transcription quantitative polymerase chain reaction (RT-qPCR)

RNA was extracted with TRIzol reagent (Ambion, Thermo Fisher), treated with 1 unit DNase I (Thermo Fisher) for 60 min and reverse-transcribed using random primers (Thermo Fisher Scientific) and SuperScript III (Invitrogen). The resulting complementary DNAs were used for quantitative polymerase chain reaction (qPCR) using KAPA SYBR Fast qPCR Master Mix (Kapa Biosystems) in a BioMolecular Systems MIC instrument. Primer design was according to MIQE guidelines. All primer pairs fulfilled quality criteria regarding amplification efficiency and melting curves. The primer sequences are listed in Supplementary Table S1. The polymerase chain reaction (PCR) primers used for analysis of snoRNA:U3:9B are also shown in Supplementary Fig. S1. The results presented are compiled data from multiple independent biological replicates, each analysed in duplicate. For each experiment, the number of independent replicates is provided in the figure legend. For analysis of snoRNA abundance in knock-out strains where the sequences analyzed are undetectable, the maximum number of 40 cycles has been used for delta Ct calculations.

RNA fluorescence in situ hybridization and immunofluorescence

Larval salivary glands were dissected and fixed with 3.6% formaldehyde in phosphate-buffered saline (PBS) containing 1% Triton X-100 for 40 s followed by 2 min in 3.6% formaldehyde/50% acetic acid solution. The glands were squashed in lactoacetic acid (lactic acid:water:acetic acid; 1:2:3) and the coverslips flipped-off after freezing the preparations in liquid nitrogen. Chromosome squashes we prehybridized with 10 μl hybridization buffer (HB) containing 2× saline sodium citrate (SSC) buffer, 50% formamide and 5% dextran sulfate for 30 min at 42°C. Probe mix was freshly prepared and contained 1.2 μl probe at 1.2 μg/ml, 0.4 μl salmon sperm DNA (10 mg/ml), and 8.4 μl HB. Hybridization was for 1 h at 42°C. The slides were washed sequentially with the following solutions for 3 min each: 50% formamide at 42°C, 5× SSC at 42°C, 2× SSC at 42°C, 0.1× SSC at room temperature, and 1× PBS/10% Tween 20 (PBT) at room temperature. The slides were then blocked with 3% bovine serum albumin (BSA) in PBT for 45 min and incubated with primary antibody (anti-DIG-FITC; Roche, 11209941910). After washing in PBT twice for 3 min each, slides were incubated with secondary antibody (anti-FITC- Alexa488, Molecular Probes, A11090) for 40 min at 37°C, washed again with PBT and mounted using 10 μl Vectashield with DAPI (4′,6-diamidino-2-phenylindole, Vector Laboratories, H-1200-10). The preparations were counterstained with antibodies against either H3K9ac (Abcam, ab10812), Df31 (kind gift from Jordan Rowley, University of Nebraska Medical Center), RNApolII (Abcam, ab5408) or Fibrillarin (Abcam, ab5821). The slides were examined in an Axioplan fluorescence microscope (Carl Zeiss). The probe sequences are listed in Supplementary Table S1 and shown in Supplementary Fig. S1.

Bioinformatics analyses

RNA-seq data was obtained from Planells et al. [56] [GEO accession GSE222262]. Normalized reads (transcripts per million, TPM) were computed individually for each replicate and averaged (N = 3). Transcript biotype information was obtained from the ensembl BDGP6.28.100 reference gene annotation. ChAR-seq [3] [GEO accession GSE97131] RNA–DNA contacts mapped to D. melanogaster dm3 assembly were converted to dm6 using rtracklayer::liftOver function in Bioconductor and the UCSC chain file (dm3Todm6). Exon-intron assignment of ChAR-seq RNA–DNA contacts was performed using the R package annotatr [58].

Gene ontology analyses were carried out using ShinyGO 0.81 [59]. Motif analysis was performed using the MEME suite. The 500 bp sequence upstream of transcription start site (TSS) of chromatin-associated snoRNAs (ca-snoRNAs) was obtained using ensembl biomart and uploaded to the XSTREME tool [60] under the MEME suite. SnoGloBe [19] was used to predict RNA–RNA interactions of snoRNA:U3:9B, snoRNA:185, and snoRNA:28S-A2468 against the entire transcriptome of the Ensembl BDGP6.46.110 assembly release (excluding chromosome scaffolds), using the following settings: -n 10 -t 0.95 -m -w 3 –seq. The STREME tool [61] under the MEME suite was used to identify novel motifs in the snoRNA:U3:9B target sequences predicted by snoGlobe.

Drosophila stock maintenance

All fly stocks were reared on instant potato mash–agar food in mixed female/male populations at 25°C, 60% relative humidity, and a 12-h light/12-h dark cycle.

Microbial infections

Bacterial overnight cultures of Entercoccus faecalis or Micrococcus luteus were washed once and resuspened in PBS at OD 1. A field isolated strain of Sindbis virus (genus Alphavirus, family Togaviridae), genotype I (09M-99[1]-1) was grown in Vero cells [62]. A vesicular stomatitis virus (VSV) strain, VSV-GFP, was grown in Vero cells as previously reported [63]. Late second instar larvae were injected with either 50 nl of bacterial suspension, 50 nl of 4.0e + 9 plaque forming units/ml (PFU/ml) VSV-GFP or 50 nl of 3.4e + 9 PFU/ml Sindbis virus through the cuticle towards the posterior end. Larvae injected with the same volume of either PBS or Dulbecco’s modified Eagle’s medium (DMEM; Gibco) supplemented with 10% FBS (Gibco) served as mock-infected controls. w1118 larvae were used as background strain. Following injection, animals were maintained at 29°C. Five brains per replicate were harvested 24 h after injection for RNA extraction and RT-qPCR analysis.

Sindbis infection model in flies

Transgenic flies expressing SINrep:GFP or SINΔrep:GFP were obtained from Richard Hardy, Indiana University, and crossed with Act > GAL4 (BL#3954) stock to drive the expression of the SIN replicons.

CRISPR/Cas9 alleles and generation snoRNA knock-outs

The gRNAs targeting snoRNA:U3:9B and snoRNA:Me28S-A2486 were designed using the targetFinder tool (http://tools.flycrispr.molbio.wisc.edu/targetFinder/). Primers containing homology to the target genes (listed in Supplementary Table S1) were annealed and cloned into the pCFD4 plasmid [64] at the BbsI site using Gibson Assembly (NEB). The resulting plasmids were sequence verified, purified with the NucleoBond Xtra Midi kit (Macherey-Nagel, Cat. 740410.50) and inserted into the attP40 landing site (FlyORF Injection Service). Transgenic flies were identified by their vermilion+ eye phenotype. The knock-outs were generated by crossing with vasa-cas9 fly stock and genetic screening was performed according to standard protocol (https://flycrispr.org/wp-content/uploads/2019/07/ssODN-molecular-screening-work-flow.pdf). The deletions were confirmed by genomic DNA PCR and Sanger sequencing.

RNA sequencing and data analysis

RNA was extracted as described above, in triplicates. The siTOOLs riboPOOL kit was used for rRNA depletion. Paired-end strand-specific libraries were prepared using NEBNext Ultra II directional RNA library Prep Kit for Illumina (NEB) according to the manufacturer’s instructions. Total RNA-seq was performed by the core facility for Bioinformatics and Expression Analysis (Karolinska Institute, Huddinge, Sweden) on a NextSeq 2000 P2 (100 cycles, 2 × 58 bp) sequencer aiming for an average depth of 15 million reads per sample. RNA-seq data was processed using nf-core/rnaseq v3.12.0 [65]. The pipeline was executed with Nextflow v23.10.1 [66]. Briefly, raw RNA-seq reads were aligned to the D. melanogaster reference genome (dm6). The resulting BAM files were then imported into R (version 4.3.2) for further processing and differential expression analysis. Batch effects were corrected using Surrogate Variable Analysis. Differential gene expression was performed using DESeq2 [67] with models based on a negative binomial distribution, producing a final set of differentially expressed gene lists for downstream analyses (false discovery rate, FDR < 0.05).

Assay for transposase-accessible chromatin-qPCR in S2 cells and third instar larval brains

Tagmentation reaction in S2 cells was performed according to assay for transposase-accessible chromatin (ATAC)-seq method [68] using Nextera DNA library kit (FC-121–1030). Tagmentation reaction from five brains dissected from third instar larvae was performed according to Dhall et al. [69]. The purified tagmented DNA was analyzed by ATAC-qPCR using the primers listed in Supplementary Table S1.

ATAC sequencing and data analysis

The samples (in triplicates) were prepared as described above for ATAC-qPCR. Libraries were sequenced by the core facility for Bioinformatics and Expression Analysis (Karolinska Institute, Huddinge, Sweden) on NextSeq 2000 P3 (100 cycles) sequencer obtaining paired-end reads (2 × 61bp). The average depth was over 60 million reads per sample. ATAC-seq data was processed using the nf-core/atacseq v2.0 pipeline (https://nf-co.re/atacseq/2.0), executed with Nextflow v23.04.2. Briefly, raw FASTQ files were quality-checked with FastQC, adapters were trimmed with TrimGalore, and reads were aligned to the D. melanogaster reference genome (dm6) using BWA. Blacklisted regions [70] were excluded based on the dm6-blacklist.v2.bed. Differential accessibility was assessed using a window-based approach in the csaw package [71] in R (version 4.3.2). Three normalization methods—TMM, Lowess, and Full Quantile (FQ)—were tested, with FQ normalization yielding the most consistent results. Differential accessibility gene lists were generated for further analysis (FDR < 0.05).

Sindbis infection model in S2 cells

The pSINrep:GFP, kindly donated by Richard Hardy, was digested with RsrII and KpnI to create the pSINΔ:GFP plasmid as described in Avadhanula et al. [72]. The plasmids were stably transfected into S2 cells using a calcium phosphate transfection kit (Invitrogen, cat. no. 44-0052) and hygromycin selection. Expression of the SIN replicon in stable cell lines was induced by transfection of pAc-GAL4 (Addgene, #24344) following standard procedures for transient transfection. The cells were harvested and analyzed 48 h after transfection.

SnoRNA depletion by RNAi in S2 cells

The plasmid pValium20(also known as UAS-shRNA) was used for the generation of short hairpin RNAs (shRNAs). Complementary oligonucleotides were annealed and ligated into pValium20 [73] digested with NheI and EcoRI. The sequence of the oligonucleotides is given in Supplementary Table S1. The shRNA–snoRNA plasmids were transiently transfected into SIN replicon S2 cells along with pAc-GAL4 using standard methods, and the cells were harvested and analyzed 48 h after transfection. The sequence targeted by the shRNA is shown in Supplementary Fig. S1.

Chromatin isolation by RNA purification in third instar larval brains

100 brains were dissected from ActGAL4 > SIN and ActGAL4 > SINΔ third instar larvae and chromatin isolation by RNA purification (ChIRP) was performed according to Chu et al. [74]. The biotin labeled anti-sense snoRNA probes used for pull down are listed in Supplementary Table S1. The purified RNA from the input and pull down samples was analyzed by quantitative reverse transcriptase-polymerase chain reaction to examine the specificity of the pull down using specific oligonucleotides. The purified DNA was analyzed by qPCR using oligonucleotides listed in Supplementary Table S1.

Chromatin immunoprecipitation from larval brains

ChIP was performed as described by Botelho et al. [75] using the anti-rat Brg1 antibody [76] that recognizes the Drosophila Brahma protein. Briefly, 50 larval brains were used for each immunoprecipitation. The larval tissue was fixed in 2% formaldehyde followed by chromatin shearing to fragment sizes in the 200–900 bp range. Immunoprecipitation was performed with pre-cleared lysate overnight at 4°C using 10 μg/ml of anti-Brg1 antibody and Rabbit IgG as a negative control (Abcam, ab46540). A mix of Protein A and G Dynabeads (Invitrogen) blocked with 1 mg/ml BSA and 1 mg/ml salmon sperm DNA was used to capture antibody-chromatin complexes for 90 min, followed by four 5-min washes with radioimmunoprecipitation assay (RIPA) buffer containing 0.7% sodium deoxycholate. Further, the beads were washed once with 0.05 M Tris–HCl (pH 8.0), 2 mM EDTA. 10% of washed beads were reserved for RNA purification with TRIZOL (Invitrogen) after proteinase K treatment to reverse the crosslinking. The immunoprecipitated RNA was reverse transcribed and analyzed by RT-qPCR using standard protocols. The remaining 90% of the material was processed for DNA analysis. The crosslinking was reversed in Tris EDTA (TE) buffer containing 0.05% sodium dodecyl sulfate, 0.1 mg/ml RNase A, and 0.2 mg/ml proteinase K (Thermo Scientific) at 55°C for 3 h, and subsequently at 65°C overnight. The immunoprecipitated DNA was purified using the ChIP DNA Clean & Concentrator kit (ZymoResearch, D5205). For qPCR analysis, the KAPA SYBR Fast qPCR Kit (KAPA Biosystem) was used in BioMolecular Systems MIC instrument. The purified DNA was analyzed by qPCR using oligonucleotides listed in Supplementary Table S1.

Pupation assays

50 first instar larvae from SIN, Δ9B1;SIN, Δ9B3;SIN, and ΔA2486 with and without GAL4 were collected and distributed in fresh food vials. The number of larvae developing into pupae was monitored for 7 days. Percent pupation was calculated for each genotype relative to the number of pupae in controls without GAL4. Three biological replicates were performed, each with 50 animals for each genotype.

In another series of experiments, early second instar larvae were injected with 50 nl of 3.4e + 9 PFU/ml viral stock through the cuticle towards the posterior end. An injection of the same volume of DMEM (Gibco) supplemented with 10% FBS (Gibco) served as a mock-infected control. w1118 larvae were used as background strain. Following injections, larvae were transferred to new vials and maintained at 25°C. They were monitored up to five days to follow pupation. Percentage of pupation was calculated for each genotype relative to the number of pupae in control samples. Three biological replicates were performed, each with 50 animals for each genotype.

Statistical testing

In bar plots, the bars show average values and the error bars represent standard deviations unless otherwise indicated. The number of biological replicates for each experiment and the statistical tests used in each case are indicated in the figure legends. All plots and statistical analyses were performed using GraphPad Prism 10. Analyses of two sample means were performed using a two-tailed Student’s unpaired t-test, if the data passed normality test (Shapiro–Wilk test). Equal variances between the groups were ensured using an F-test (P>.05). For grouped data, one-way or two-way analysis of variance (ANOVA) combined with a two-stage linear step-up procedure of Benjamini, Krieger, and Yekutieli was applied. Probability values (padj) for statistically significant differences are provided in the figures.

Results

Identification of ca-snoRNAs in Drosophila S2 cells

We recently profiled caRNAs isolated from the chromatin fraction of S2 cells [56]. The analysis of a size-fractionated caRNA pool in the 0–500 nt range showed that snoRNAs constitute a large portion of the noncoding, chromatin-associated transcriptome (Fig. 1A). Additionally, analysis of the total chromatin fraction indicated that, despite considerable differences in the relative abundances of individual snoRNAs, snoRNAs as a biotype are significantly enriched in the chromatin (Fig. 1B). The chromatin-enriched snoRNAs are listed in Supplementary Table S2 and include both C/D box and H/ACA snoRNAs. The chromatin enrichment of selected snoRNAs was validated by RT-qPCR (Fig. 1C). An independent ChAR-seq study based on RNA–DNA proximity ligation identified a similar set of ca-snoRNAs in CME-W1-cl8+ Drosophila wing disc cells [3].

Figure 1.

Figure 1.

Identification of ca-snoRNAs in D. melanogaster. (A) Relative distribution of normalized counts per transcript for each noncoding RNA biotype, corresponding to the 28.7% of the total chromatin counts. Protein coding genes (71.3%) are not represented in the plot. (B) RNA abundances in total and chromatin RNA preparations normalized by length and sequencing depth (TPM). Nonparametric Wilcoxon rank test was used for statistical testing of RNA abundances. Counts have been log-transformed for visualization purposes. (C) Scatter plot showing the expression level of different ca-snoRNAs in total and chromatin fractions as measured by RT-qPCR. The x- and y-axes show relative RNA levels normalized to Act5C. The axes scales are log transformed. Box C/D snoRNAs and box H/ACA snoRNAs are represented by blue and green dots, respectively. Red dots represent mRNAs analyzed in parallel as examples of chromatin depleted transcripts. Two tailed nonparametric Mann–Whitney test was used to establish the statistical significance of the enrichment in chromatin compared to total RNA. N = 3. (D) RNA fluorescence in situhybridization (RNA-FISH) using a DIG-labeled probe to show the distribution of U3 snoRNAs (lower panel) in polytene chromosomes of salivary glands of third instar larvae. The upper panel shows chromosomes hybridized in parallel with a negative control probe. Nu, nucleolus. The scale bar represents ∼25 μm. (E) RNA-FISH and immunofluorescence (IF) showing the co-localization of different proteins with U3 snoRNA in polytene chromosomes of salivary glands of third instar larvae. The names of the proteins tested are marked in each inset. The merged channel is shown in the right panel. Arrowhead indicates chromosome puff. The scale bar represents ∼10 μm.

We chose to focus our study on snoRNA:U3:9B because it was one of the chromatin-enriched snoRNAs in the two studies referred to above and because ChAR-seq identified ∼140 000 DNA contacts for this snoRNA in the genome of D. melanogaster, which suggested a widespread role for snoRNA:U3:9B in the chromatin. A meta-analysis of the ChAR-seq data confirmed that snoRNA:U3:9B was highly enriched in the chromatin of wing disc cells (Supplementary Fig. S2A).

We carried out RNA-FISH on polytene chromosomes dissected from salivary glands of third instar larvae to validate the association of snoRNA:U3:9B with the chromatin. The DIG-labeled probe, complementary to a common region in the three U3 snoRNA paralogs of D. melanogaster (see Supplementary Fig. S1), localized to many loci in the polytene chromosome (Fig. 1D, bottom panel). The labeling was highly specific as shown by comparison to a DIG-labeled probe complementary to an unrelated bacterial sequence (Fig. 1D, upper panel). The previously reported association of snoRNAs with euchromatin [33] suggested that snoRNAs bind to transcriptionally active genomic regions. To test whether this was the case for snoRNA:U3:9B, we carried out double-labeling experiments combining RNA-FISH and IF with antibodies against marker proteins. The U3 snoRNA probe co-localized to a large extent with the active histone mark H3K9ac, with RNA polymerase II, and with Df31, a protein that was shown to be required for the maintenance of open chromatin [33] (Fig. 1E). Although widely distributed, the FISH signal in active loci was gene specific as revealed by the observation that certain chromosome puffs, which were intensely stained by the anti-RNA polymerase II antibody, were not labeled by the U3 snoRNA probe (white arrowhead in Fig. 1E).

Interestingly, double-labeling FISH experiments with an antibody against Fibrillarin showed a very low degree of colocalization (Fig. 1E, bottom panel), which suggests that U3 snoRNAs are associated to chromatin as part of a noncanonical snoRNP complexes that lack Fibrillarin.

The FISH probe used was capable of detecting all U3 snoRNA paralogues in D. melanogaster. To more precisely determine the association of snoRNA:U3:9B with open chromatin, we intersected the ChAR-seq data from Bell et al. [3] with available marker protein datasets. Interestingly, 90% of Df31 bound genes identified by Filion et al. [77] using DamID, and 95.8% of H3K9ac ChIP-seq peaks [3] overlapped with ChAR-seq contacts for snoRNA:U3:9B (Supplementary Fig. S2B). Together with the FISH results reported above, these observations strongly support the association of snoRNA:U3:9B with active chromatin.

Widespread localization in the polytene chromosomes and association with transcriptionally active chromatin were not unique to snoRNA:U3:9B and a DIG-labeled probe against another ca-snoRNA, snoRNA:185, also labeled many loci in the polytene chromosomes (Supplementary Fig. S2C and D).

In summary, we have identified ca-snoRNAs in Drosophila S2 cells and shown that snoRNA:U3:9B co-localizes with many transcriptionally active loci in the Drosophila genome.

A meta-analysis of snoRNA binding sites links snoRNA:U3:9B to signaling pathways and to the immune response

We mined the available ChAR-seq data [3] and classified the DNA contact points for snoRNA:U3:9B and snoRNA:185 according to gene features. Both snoRNAs were preferentially enriched in exonic sequences and slightly underrepresented in intronic and intergenic sequences (Fig. 2A and Supplementary Fig. S3), which suggests that snoRNA recruitment to transcribed genes is at least partially mediated by the nascent mRNA.

Figure 2.

Figure 2.

SnoRNA:U3:9B binds to protein-coding genes related to signaling pathways and is induced in response to viral infection. (A) Meta-analysis of ChAR-seq data [3]. The bar plot shows the association of snoRNA:U3:9B contact sites with specific gene features compared to the reference genome. Two-sample proportional z-test with Benjamini-Hochberg correction was used to assess the statistical significance of differences between the distributions. (B) Gene ontology enrichment analysis of Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway of genes with at least 10 snoRNA:U3:9B binding sites according to ChAR-seq. The plot shows the top 10 KEGG pathways. Statistical significance is color-coded. The x-axis shows the fold enrichment of genes in each category. The size of the dot indicates the number of genes in each category. (C) Jitter plot showing the normalized expression of snoRNAs (n = 278) and a random set of genes (n = 278) in third instar larvae expressing the SIN replicon (Sindbis treatment) and in control animals not expressing the SIN replicon (Control, isogenic strain y1; cn bw1sp1). Data from the modENCODE project [78]. The y-axis shows normalized RPKMs as measured in modENCODE RNA-seq. Two-tailed unpaired Kolmogorov–Smirnov test was used to compare the data sets. (D) A total of 10 out of the 143 snoRNAs upregulated by the Sindbis treatment (see text for details) are expressed from independent genes (highlighted in red in Supplementary Table S2). The figure shows the sequence logo of the lola-PO binding motif identified by XSTREME [60] in these 10 genes (E-value = 5.95e-05, n = 10). The lower panel shows the position of the identified motif relative to the TSS. Two control sets of uninduced snoRNAs (including independent and polycistronic) or random protein coding genes were tested in parallel and no motif occurrence was identified in any of the sets (not shown). (E) Analysis of snoRNA expression in infected larvae. Bacteria or virus preparations were injected into third instar larvae, RNA was extracted from larval brains dissected 24 h after infection. SnoRNAs expression was analyzed by RT-qPCR and normalized to Act5C. Mock infected animals were analyzed in parallel. The RNA levels are expressed as log2 fold change compared to mock infected controls. Multiple comparisons were carried out using ordinary one-way ANOVA combined with a two-stage step-up procedure of Benjamini, Krieger, and Yekutieli. Adjusted P-values are shown in the figure. N = 3.

According to the ChAR-seq data from Bell et al.[3], snoRNA:U3:9B makes 142 267 contacts in the D. melanogaster genome and is associated with 10 057 out of the 17 864 annotated genes. The number of contacts per gene ranged from 1 to 2460. Selection of genes with at least 10 contact points resulted in a list of 2492 genes which were the most preferred snoRNA:U3:9B bound genes (hereinafter referred to as snoRNA:U3:9B target genes). A gene ontology enrichment analysis of the 2492 snoRNA:U3:9B target genes revealed significant links to KEGG pathway terms MAPK/JNK signaling (enrichment FDR = 5.58e-05) and Hippo signaling (enrichment FDR = 1.53e-08) (Fig. 2B). These signaling pathways are involved in a variety of biological processes including the regulation of immune responses in mammals [53, 54]. The snoRNA:U3:9B target genes included 23 Toll pathway genes, and 16 Imd pathway genes (see Supplementary Table S3). These observations suggested a possible link between snoRNA:U3:9B and the immune responses of D. melanogaster. Interestingly, the analysis of publicly available data from the modENCODE gene expression project [78], which describes transcriptome changes in response to different experimental treatments, revealed that the expression of snoRNA:U3:9B was remarkably increased upon Sindbis virus treatment (Supplementary Table S2). The Sindbis virus treatment in modENCODE consists of expression of a noninfectious Sindbis replicon in a transgenic fly strain [72]. We compared the expression of each annotated snoRNA upon Sindbis treatment to its expression in untreated wild-type larvae (L3 puff stage 7–9). Interestingly, not only snoRNA:U3:9B but as many as 144 out of the 278 annotated snoRNA genes were induced by the Sindbis treatment in third instar larvae (Fig. 2C). Out of these 144 snoRNAs, 105 were found to be chromatin associated in our caRNA analysis (Supplementary Table S2).

We further investigated whether there was any underlying regulatory feature in the TSS of Sindbis-induced snoRNAs. Out of 144 induced snoRNAs, only 10 are transcribed from independent genes. The remaining 134 are derived from either introns or polycistronic host genes, with only two of these showing upregulation upon Sindbis treatment. Thus we searched for known motifs upstream of the TSS of the 10 independent snoRNA genes that were induced by the Sindbis treatment (highlighted in Supplementary Table S2). As compared to a control set of uninduced snoRNAs or random protein coding genes, the set of 10 virus-induced snoRNAs harbored binding motifs for the transcription factor lola (longitudinals lacking, lola-PO) (Fig. 2DE-value = 5.95e-05). The lola motif was identified in nine out of ten snoRNAs and was located in a window 400–500 bp upstream of the TSS (Fig. 2D). Previous studies have shown that lola is implicated in the regulation of immune signaling pathways [79, 80].

To investigate whether snoRNA induction is a general response to immune challenges in Drosophila, we performed different microbial infections in early third instar larvae and quantified the expression of two ca-snoRNAs in larval brain 24 h post infection. The levels of snoRNA:U3:9B and snoRNA:185 increased significantly following Sindbis virus infection (Fig. 2E), but were not affected by infection with Gram-negative Enterobacter cloacae β12 or Gram-positive M. luteus. Infection with a VSV also resulted in snoRNA:U3:9B and snoRNA:185 upregulation (Supplementary Fig. S4). These results linked ca-snoRNAs to viral infection. The modest increase in the expression of these snoRNAs suggests that they are unlikely to function as antiviral effectors. Rather, snoRNA:U3:9B and snoRNA:185 may play a regulatory role in the antiviral immune response.

The association of ca-snoRNAs with the chromatin and with signaling pathway genes in particular, and the induction of snoRNAs following a viral infection were interesting observations that suggested a function for some snoRNAs in regulating chromatin changes related to antiviral responses.

The Sindbis replicon as a model to study the activation of immune response genes

We used the Sindbis infection model developed by Avadhanula et al. [72] to study the function of snoRNA:U3:9B and its impact on the expression of antiviral genes. This Sindbis infection model utilizes an engineered Sindbis replicon in which the structural protein genes have been replaced by a GFP cassette (Fig. 3A). The resulting replicon has the potential to replicate but fails to produce infectious particles. The fly strain carrying this Sindbis-GFP replicon, initially called SINrep:GFP, is hereafter referred to as “SIN” for short. A related strain, SINΔrep:GFP (hereafter referred to as “SINΔ”), carries a deleted Sindbis replicon that lacks most of the nonstructural protein coding sequences nSP1-4. In these strains, the expression of the Sindbis replicon was induced by crossing SIN (or SINΔ as a control) with flies that express the GAL4 driver under the control of the Act5C promoter (ActGAL4). A representative image of SIN third instar larvae expressing the Sindbis replicon driven by ActGAL4 and traced by GFP expression is shown in Fig. 3B. The control driverless larvae are hereafter referred to as neg control > SIN.

Figure 3.

Figure 3.

SIN replicon expression induces the expression of immune response genes in third instar larvae. (A) Schematic representation of the Sindbis replicon model. SIN encodes the 5′ cap, four nonstructural proteins, and a GFP open reading frame under the control of the sub-genomic promoter. SINΔcarries a deletion of nonstructural protein sequences. The replicon is expressed under the control of the UAS/GAL4 system. (B) Representative fluorescence images of third instar larvae showing the expression of GFP in control SIN (upper) and ActGAL4 > SIN (lower). (C) Bar plot showing the induction of ca-snoRNA expression in dissected brains of SIN third instar larvae with and without ActGAL4 driver. The graph also shows the lack of induction of ca-snoRNAs in SINΔ larval brains with and without ActGAL4. The expression was measured by RT-qPCR and normalized to Act5C. The RNA levels are expressed as log2 fold change compared to the respective controls. Two tailed Student’s unpaired t-test was used to compare the data sets. N = 3. (D) Bar plot showing the induction of target immune response genes in the same four conditions described in panel (C). The expression was measured by RT-qPCR and normalized to Act5C. The RNA levels are expressed as log2 fold change compared to controls. Two tailed Student’s unpaired t-test was used to compare the data sets. N = 3.

The level of expression of different ca-snoRNAs was measured in two organs from third instar larvae: brain because the Sindbis virus is known to infect neurons [81] and cardia because of the prominent role of the gut in the Drosophila immune response [82]. GAL4-driven expression of the SIN replicon, but not expression of the SINΔ replicon, resulted in significant upregulation of several ca-snoRNAs in both brain and cardia (Fig. 3C and Supplementary Fig. S5A, respectively), in agreement with the modENCODE data reported in Fig. 2C. Neither snoRNA:U3:9B nor snoRNA:185 were induced in ActGAL4 > SINΔ larvae, which directly links the increased expression of selected snoRNAs to the activation of the SIN replicon.

We also asked whether the activation of the SIN replicon would induce the expression of antiviral response genes. We analyzed by RT-qPCR the relative expression of transcripts from some snoRNA:U3:9B target genes identified by ChAR-seq that were ascribed to the immune response pathway. Larvae expressing the SIN replicon (ActGAL4 > SIN larvae), but not ActGAL4 > SINΔ larvae, showed increased expression of selected immune response genes in brain and cardia, as shown in Fig. 3D and Supplementary Fig. S5B, respectively. Specifically, genes such as Vago [47], DptB [83] or Tep2 [84] that are known to be induced upon Sindbis virus infection were significantly upregulated in our infection model. In summary, these results showed that expression of the SIN replicon in third instar larvae resulted in increased expression of a subset ca-snoRNAs and target immune response genes.

SnoRNA:U3:9B is required for the activation of immune response genes

We created two independent snoRNA:U3:9B knockout fly strains using standard gRNA mediated CRISPR-Cas9 technology to investigate the functional importance of snoRNA:U3:9B in vivo (Supplementary Fig. S6A). The specificity of the deletions was confirmed by PCR analysis of single fly genomic DNA (Supplementary Fig. S6B). The two deletion lines, Δ9B1 and Δ9B3, were viable. They were crossed with SIN flies to create snoRNA:U3:9B knockout SIN flies (Δ9B1;SIN and Δ9B3;SIN). In all cases, the expression of the SIN replicon was driven by ActGAL4. RT-qPCR analysis of nSP1 and GFP expression showed that the SIN replicon was expressed at similar levels in wild-type, snoRNA:U3:9B deletion strains, and a control snoRNA deletion ΔA2486 strain (Supplementary Fig. S6C). The snoRNA levels were also measured in these backgrounds to confirm the snoRNA deletions in the knockout strains as well as the induction of snoRNA:U3:9B expression in the wild-type strains (Supplementary Fig. S6D). SnoRNA:U3:9B was undetectable in the Δ9B1 and Δ9B3 flies, and significantly induced in both wild-type or ΔA2486 knockout on ActGal4-driven SIN replicon expression (Supplementary Fig. S6D). The levels of snoRNA:U3:54Aa/b and snoRNA:185 remained unchanged in the deletion strains.

We profiled the brain transcriptome of wild-type and snoRNA:U3:9B knockout larvae, with and without SIN replicon expression (Supplementary Fig. S7). A principal component analysis indicated that deletion of snoRNA:U3:9B did not cause major changes in the transcriptome of infected larval brain (Supplementary Fig. S7A). The targeted analysis of 489 genes annotated as immune response genes (GO:0002376) did not reveal global effects of snoRNA:U3:9B deletion on the immune response, but identified a few immune response genes that were differentially expressed in response to SIN replicon expression in wild-type but not in snoRNA:U3:9B knockout larvae (Fig. 4A). For instance, MP1, a gene that encodes a serine proteases that cleaves Spätzle and activates the Toll pathway [85], was significantly upregulated upon expression of the SIN replicon in wildtype conditions but not in snoRNA:U3:9B knockout larvae (Fig. 4A and E). Interestingly, many AMP genes that were normally upregulated upon expression of the ActGAL4 > SIN replicon in wildtype larvae were unchanged or showed decreased expression in Δ9B1; ActGAL4 > SIN and Δ9B3; ActGAL4 > SIN larvae (Fig. 4B and C). In many cases, the differences in AMP gene expression observed in the RNA-seq analysis were not statistically significant due to variability in the AMP gene activation levels. Although the cause of this variation remains unclear, it may be related to the use of ActGAL4-mediated activation of the SIN replicon, which starts already in embryos and could trigger secondary effects, thereby contributing to variability in the magnitude of the response. In spite of this variability, the differences were reproducible throughout replicates and could be validated by RT-qPCR (Fig. 4D). RT-qPCR also demonstrated significant defects in the induction of other innate immune genes such as Vago, PGRP-SD and vir-1 that were not identified by the differential expression analysis due to large variability in the extent of the responses (Fig. 4E). In summary, the loss-of-function experiments presented above showed that depletion of snoRNA:U3:9B does not cause widespread disruption of the transcriptome. Instead, it specifically inhibits the transcriptional activation of a subset of immune response genes, which demonstrates a role for snoRNA:U3:9B in the immune response to Sindbis virus.

Figure 4.

Figure 4.

SnoRNA:U3:9B deletion inhibits the activation of target immune response genes in response to SIN replicon expression. (A) Scatter plot comparing the transcriptional immune response to SIN expression in snoRNA:U3:9B knock-out (Δ9B1; ActGAL4 > SIN versus Δ9B1; neg control > SIN, x-axis) and wild-type (ActGAL4 > SIN versus neg control > SIN, y-axis) larval brains. In each strain, changes in normalized RNA levels for transcripts categorized under GO:immune system process (GO:0 002 376) with and without GAL4 were expressed as log2 fold change (log2FC). The plot shows data from three independent biological replicates. Transcripts in green were differentially expressed (padj< 0.05) in response to SIN replicon expression only in wild-type (SIN), blue transcripts only in snoRNA:U3:9B knockout (Δ9B1; SIN), and red transcripts in both conditions. Two transcripts that were significantly changed only in Δ9B1; ActGAL4 > SIN versus Δ9B1; neg control > SIN, namely IM1 (log2FC = −16.11017754, padj= 2.95e-08) and mRpL53 (log2FC = −23.45474574, padj= 9.12e-04), showed extreme values and were removed from the scatter plot for representation purposes. (B) Representative genome browser screenshots of RNA-seq signal in wild-type (SIN) and snoRNA:U3:9B knock out (Δ9B1;SIN) with and without expression of SIN replicon. The signal tracks represent coverage of normalized reads from three independent biological replicates across the genome. The thick blue boxes represent exons, lines represent introns, and the arrowheads indicate the gene direction. (C) Heat map showing AMP gene expression changes in brains of wild-type (ActGAL4 > SIN versus neg control > SIN) or snoRNA:U3:9B knock-out larvae (Δ9B1; ActGAL4 > SIN versus Δ9B1; neg control > SIN and Δ9B3; ActGAL4 > SIN versus Δ9B3; neg control > SIN) in response to SIN replicon expression. Log2FC reflects mean value comparing with and without GAL4 from three independent biological replicates. (D) Bar plot showing the activation of AMP genes in larval brains in response to SIN replicon expression. Expression levels were quantified in brains from SIN replicon expressing third instar larvae in wild-type (ActGAL4 > SIN versus neg control > SIN), control snoRNA knock-out (ΔA2486; ActGAL4 > SIN versus ΔA2486; neg control > SIN) or snoRNA:U3:9B knock-out lines (Δ9B1; ActGAL4 > SIN versus Δ9B1; neg control > SIN and Δ9B3; ActGAL4 > SIN versus Δ9B3; neg control > SIN) by RT-qPCR, normalized to Act5C and expressed as log2FC relative to normalized expression in brains without GAL4. Multiple comparisons were carried out using ordinary one-way ANOVA combined with a two-stage step-up procedure of Benjamini, Krieger, and Yekutieli. Adjusted P-values are shown in the figure. N = 3. (E) Bar plot showing the expression of selected snoRNA:U3:9B target immune response genes in larval brains in response to SIN replicon expression. Expression levels were measured by RT-qPCR as in panel (D). N = 3.

Changes in chromatin accessibility related to the activation of immune response genes require snoRNA:U3:9B

A previous study on a possible role for snoRNAs in maintaining open chromatin states [33] and the fact that snoRNA:U3:9B was associated with chromatin [3, 56] prompted us to study whether the effect of snoRNA:U3:9B on the expression of immune response genes entailed changes in chromatin accessibility. We carried out ATAC-seq experiments in wild-type and snoRNA:U3:9B knockout larvae upon GAL4-driven expression of the SIN replicon (Supplementary Fig. S8A).

A differential accessibility analysis revealed that snoRNA:U3:9B deletion resulted in severe chromatin changes in the absence of any immune challenge. A total of 1376 differentially accessible regions were detected in Δ9B1; neg control > SIN and Δ9B3; neg control > SIN larvae compared to wild-type. These regions were located at or near 978 genes. A gene ontology enrichment analysis revealed that the affected genes were linked to developmental and morphogenetic processes (Supplementary Fig. S8B and C), which suggests that snoRNA:U3:9B is required to maintain the chromatin homeostasis of regulated genes.

The ATAC-seq analysis of ActGAL4 > SIN larvae identified 297 differentially accessible regions located at or near 201 genes in snoRNA:U3:9B knockout compared to wild-type (Supplementary Fig. S9). The targeted analysis of accessibility changes in the 489 genes annotated as immune response genes (GO:0002376) revealed changed accessibility in several genes that code for immune regulators. For example, multiple regions with increased accessibility in wild-type but not in snoRNA:U3:9B knockout larvae were identified at/near the Slmap gene, which codes for a negative regulator of the Hippo and Imd pathways [86]. Other affected genes were Dif, which encodes a NF-κB type transcription factor that regulates AMP expression through the Toll pathway [87] and Toll-7, which induces antiviral autophagy [88] (Fig. 5A and B).

Figure 5.

Figure 5.

SnoRNA:U3:9B regulates the chromatin accessibility of immune response genes in SIN replicon expressing larvae. (A) Scatter plot showing differentially accessible regions (as measured by ATAC-seq) in genes categorized under GO:immune system process (GO:0002376) in larval brains in snoRNA:U3:9B knock-out (Δ9B1; ActGAL4 > SIN versus Δ9B1; neg control > SIN, x-axis) and wild-type (ActGAL4 > SIN versus neg control > SIN, y-axis). Accessibility changes are expressed as log2FC comparing with and without GAL4 from three independent biological replicates. Regions in green were differentially accessible (padj< 0.05) in response to SIN replicon expression only in wild-type (ActGAL4 > SIN versus neg control > SIN), blue dots represent regions that were significant only in snoRNA:U3:9B knockout (Δ9B1; ActGAL4 > SIN versus Δ9B1; neg control > SIN), and red regions showed significant changes in both conditions. (B) Representative genome browser screenshots showing changes in ATAC-seq signal in wild-type (ActGAL4 > SIN versus neg control > SIN) and snoRNA:U3:9B knock out (Δ9B1; ActGAL4 > SIN versus Δ9B1; neg control > SIN) with and without expression of SIN replicon. The signal tracks show ratios of normalized ATAC-seq signals. (C) Bar plots showing differentially accessible regions at AMP genes in brains of SIN replicon expressing third instar larvae in wild-type (ActGAL4 > SIN versus neg control > SIN), control snoRNA knock-out (ΔA2486; ActGAL4 > SIN versus ΔA2486; neg control > SIN) or snoRNA:U3:9B knock-out (Δ9B1; ActGAL4 > SIN versus Δ9B1; neg control > SIN and (Δ9B3; ActGAL4 > SIN versus Δ9B3; neg control > SIN). The accessibility was measured by ATAC-qPCR, normalized to a silent heterochromatic region in chr2R, and expressed as log2FC relative to control brains without GAL4. The primer sequences and genomic coordinates for the analyzed regions are provided in Supplementary Table S1. Multiple comparisons were carried out using ordinary one-way ANOVA combined with a two-stage step-up procedure of Benjamini, Krieger, and Yekutieli. Adjusted P-values are shown in the figure. N = 3. (D) Bar plots showing differentially accessible regions in genes that code for immune regulators analyzed by ATAC-qPCR as in panel (C). N = 3.

ATAC-qPCR revealed that chromatin accessibility at AMP genes was normally increased upon infection in wild-type larvae (ActGAL4 > SIN) but not in snoRNA:U3:9B knockout larvae (Δ9B1; ActGAL4 > SIN and Δ9B3; ActGAL4 > SIN) (Fig. 5B and C). Moreover, the defects in the induction of genes previously linked to Sindbis virus infection (such as Vago, vir-1 or ed) or involved in the Imd pathway [such as pirk, rolled (rl)/Erk, nub, or dnr1] reported in Fig. 4E were in most cases also accompanied by defects in chromatin accessibility (Fig. 5D). These observations indicate that snoRNAU3:9B is required for the chromatin rearrangements that are associated with the activation of the antiviral response.

In a parallel series of experiments, we studied the involvement of snoRNA:U3:9B in immune activation in S2 cells. To this end, we established stable S2 cell lines by transfection of either pSIN or pSINΔ constructs, and induced SIN replicon expression in the stably transfected S2 cells by transient transfection of a pAc-GAL4 plasmid. SIN replicon expression resulted in snoRNA:U3:9B upregulation and induction of immune response genes, as in larval tissues (Supplementary Fig. S10A–C)). Moreover, the induction of immune response genes was correlated with an increase in chromatin accessibility, as demonstrated by ATAC-qPCR (Supplementary Fig. S10D). Notably, the depletion of snoRNA:U3:9B by RNA interference effectively counteracted this effect while depletion of an unrelated snoRNA did not (Supplementary Fig. S10E–G)).

Collectively, these findings revealed the importance of snoRNA:U3:9B in the regulation of antiviral gene expression and highlight its essential role in the chromatin accessibility changes that take place at specific gene loci in response to viral infection.

SnoRNA:U3:9B binds to chromatin and promotes the association of Brahma to immune response genes in response to viral infection

To elucidate the mechanistic relationship between snoRNA:U3:9B and the observed alterations in chromatin accessibility, we investigated the physical association between snoRNA:U3:9B and antiviral response genes. To this end, we performed ChIRP using fixed dissected larval brains from ActGAL4 > SIN and ActGAL4 > SINΔ larvae. In an initial series of experiments, we investigated the bound RNAs using RT-qPCR. Antisense probes specific for snoRNA:U3:9B (as-U3:9B; Fig. 6A) or snoRNA:185 (as-snoRNA:185; Supplementary Fig. S11A) effectively pulled down their respective snoRNAs, with enhanced yields observed in ActGAL4 > SIN compared to ActGAL4 > SINΔ. The observed difference in pulldown yield could be attributed, at least in part, to the increased expression levels of snoRNAs in cells expressing the SIN replicon. Both probes failed to pull down a control unrelated sequence (Fig. 6A and Supplementary Fig. S11A), which supports the specificity of the experiment, and the primers used for the RT-qPCR reactions did not amplify the probe itself (data not shown).

Figure 6.

Figure 6.

SnoRNA:U3:9B is required for the association of Brahma with target immune response genes. (A) Bar plot showing ChIRP specificity. SnoRNA:U3:9B, snoRNA:185 and a control unrelated sequence were quantified by RT-qPCR in RNA samples isolated from larval brain tissue from ActGAL4 > SIN and ActGAL4 > SINΔ by ChIRP using biotinylated DNA probes complementary to snoRNA:U3:9B (as-U3:9B). Two tailed Student’s unpaired t-test was used to compare the data sets. N = 3. (B) Bar plot showing the association of snoRNA:U3:9B with specific target genes. DNA isolated by ChIRP was analyzed by qPCR using primers for the indicated genes. ChIRP was performed using chromatin from dissected larval brain samples from ActGAL4 > SIN and ActGAL4 > SINΔ , as indicated. Two tailed Student’s unpaired t-test was used to compare the data sets. N = 3. (C) ChIP-qPCR to analyze the presence of Brahma at the TSS of immune response genes. ChIP was performed in third instar larval brains from wild-type (ActGAL4 > SIN), snoRNA:U3:9B knockout (Δ9B1; ActGAL4 > SIN) and control ActGAL4 > SINΔ lines. An IgG antibody was used in parallel as a negative control. Multiple comparisons were carried out using ordinary one-way ANOVA combined with a two-stage step-up procedure of Benjamini, Krieger, and Yekutieli. Adjusted P-values are shown in the figure. N = 3.

We subsequently analyzed the bound DNA by qPCR using primers specific to several genes previously linked to the Drosophila antiviral response. Our analysis revealed an association between snoRNA:U3:9B and target immune response genes, with this association being significantly stronger in the ActGAL4 > SIN larval brains than in those of ActGAL4 > SINΔ larvae (Fig. 6B). The as-snoRNA:185 probe also pulled down detectable amounts of DNA, but the enrichment in ActGAL4 > SIN compared to ActGAL4 > SINΔ was not significant (Supplementary Fig. S11B).

The ChIRP results presented above suggested that snoRNA:U3:9B acts locally in the chromatin, but the molecular interactions that mediate the association of ca-snoRNAs with chromatin are not understood. Based on the canonical mechanism of snoRNA action, we hypothesized that snoRNA:U3:9B forms base-pairing interactions with nascent pre-mRNAs at specific gene loci. To investigate this possibility, we used the snoRNA target prediction tool snoGloBe to identify potential RNA:RNA interactions that could explain the binding of snoRNA:U3:9B to its target genes. SnoGloBe predicted the interaction of snoRNA:U3:9B with 5S rRNA loci on chromosome 2R (Supplementary Fig. S12A, highlighted in orange) through a sequence that overlaps with the predicted canonical 3′ hinge (red line). SnoGloBe also predicted a large number of possible mRNA interaction partners for snoRNA:U3:9B in the transcriptome (n = 2857 genes with >5 interaction sites), including many immune response genes (Supplementary Fig. S10B and C). The predicted interactions mapped to both exons and introns (Supplementary Table S4), and a gene ontology (GO) analysis of the genes predicted to interact with snoRNA:U3:9B revealed a significant enrichment of signaling pathways that were very similar to those obtained for the snoRNA:U3:9B target genes identified by ChAR-seq, including the MAPK/JNK and Hippo pathways (compare Supplementary Fig. S10D with Fig. 2B).

SnoRNA:U3:9B is almost identical to two other snoRNAs encoded in the genome of D. melanogaster, snoRNA:U3:54Aa and snoRNA:U3:54Ab, but has a unique stretch of 37 nt (Supplementary Fig. S10A; nt 126–162 highlighted in green). Using a stringent P-value cutoff (P< 0.98), snoGloBe predicted 17 733 interaction sites for snoRNA:U3:9B in the transcriptome of D. melanogaster. Of these 17 733 sites, 893 sites mapped to 266 immune response genes. Among them we found the Toll-7 receptor, the MAP kinase rolled (rl)/Erk and the transcription factor nub (Supplementary Table S5). A motif search in the 17 733 target sequences predicted by snoGlobe identified three highly significant motifs (Supplementary Fig. S12A and Supplementary Table S6). Motif 1 (GCCCCGCUCCCCG) and motif 3 (UGCAGUGCAUCC), which are complementary to sequences in the unique snoRNA:U3:9B stretch (Supplementary Fig. S12A), were found in 122 and 39 immune response genes, respectively (Supplementary Table S5). SnoGlobe also predicted interactions involving sequences that are common to the three U3 snoRNAs (not shown) and the biological significance of these interactions remains to be investigated. In summary, the snoRNA:U3:9B-specific interactions predicted by snoGloBe in many immune genes, the identification of highly significant sequence motifs and the GO similarities among bound and predicted genes (identified by ChAR-seq and snoGloBe, respectively) support the proposal that direct snoRNA:pre-mRNA base-pairing interactions contribute to the targeting of snoRNA:U3:9B to specific loci in the chromatin.

We also investigated a possible mechanism through which snoRNA:U3:9B could influence chromatin accessibility. Previous studies have shown that SWI/SNF chromatin remodeling complexes regulate the expression of immune genes in mammals [89] and Drosophila [90] and, in some cases, SWI/SNF does so in cooperation with RNAs [91]. In insects, the SWI/SNF catalytic subunit Brahma associates with nascent pre-mRNAs [92], and the profiling of the SWI/SNF-RNA interactome in human cells has revealed that transcriptional activation driven by SWI/SNF often entails SWI/SNF-RNA interactions [93]. Based on these earlier observations, we hypothesized that snoRNA:U3:9B was involved in the recruitment of SWI/SNF to AMP genes. We prepared chromatin from larval brains, carried out ChIP with an anti-Brahma antibody, and analyzed the immunoprecipitated RNA by RT-qPCR. Interestingly, snoRNA:U3:9B was specifically pulled down, which shows that Brahma and snoRNA:U3:9B are present in the same chromatin environment (Supplementary Fig. S13A). Moreover, using ChIP-qPCR, we detected Brahma associated with AMP genes and with other immune genes including regulators of innate immunity such as rolled (rl)/Erk [94] and nub-RB [95] (Supplementary Fig. 13B and C and Fig. 6C). In most cases, Brahma occupancy was significantly increased in immune-challenged wild-type larvae (ActGAL4 > SIN) compared to ActGAL4 > SINΔ controls. Importantly, this increase was completely abolished in Δ9B1; ActGAL4 > SIN larvae for several of the analyzed genes such as Vago, rl, and nub-RB that encode key regulators of immune gene expression (Fig. 6C and Supplementary Fig. S13C). However, the deletion of snoRNA:U3:9B had only a modest effect on the recruitment of Brahma to AMP genes (Supplementary Fig. S13B). These results indicated a critical role for snoRNA:U3:9B in the Brahma-mediated activation of a few specific immune regulators, which is required for the subsequent activation of immune effectors such as AMPs.

Altogether, the results of the ChIRP experiments suggest that snoRNA:U3:9B is physically associated with the chromatin of a specific group of immune response genes, that this association is mediated by RNA:RNA interactions, and that snoRNA:U3:9B acts locally to facilitate the recruitment of Brahma and an open chromatin state in response to Sindbis virus infection.

SnoRNA:U3:9B is essential to survive immune stress

Next, we investigated whether the role of snoRNA:U3:9B in the chromatin and its involvement in the activation of immune response genes was physiologically relevant in vivo. The analysis of the phenotype of SIN replicon expressing flies revealed that Δ9B1; ActGAL4 > SIN and Δ9B3; ActGAL4 > SIN larvae were smaller than control ActGAL4 > SIN larvae (Fig. 7A). Scoring pupation frequencies, the pupation percentage was above 80% in the wild-type ActGAL4 > SIN strain, but only 10% and 22% in Δ9B1; ActGAL4 > SIN and Δ9B3; ActGAL4 > SIN, respectively (Fig. 7B). Interestingly, most Δ9B1; ActGAL4 > SIN and Δ9B3; ActGAL4 > SIN larvae died as feeding third instar larvae and never transitioned to wandering third instar larvae, which indicated that snoRNA:U3:9B is essential to survive the stress introduced by expression of the SIN replicon in third instar larvae. To further establish the physiological importance of snoRNA:U3:9B, we injected Sindbis virus into the hemolymph of third instar larvae and analyzed pupation frequencies as above. In mock infection experiments, the pupation frequency was ∼60% regardless of the genotype (Fig. 7C). When Sindbis virus was injected into wild-type w1118 larvae, the frequency was again ∼60%, as in mock-infected wild-type animals. However, the pupation frequency was only 40.7% and 45.6%, respectively, for Δ9B1 and Δ9B3 infected larvae. Deletion of another snoRNA, snoRNA:Me28S-A2486, did not result in significant reduction of pupation frequency (53.8%; Fig. 7C). Further, we checked the levels of viral transcripts, nSP1 and capsid protein coding gene, SINV E1 by RT-qPCR in the different fly strains with and without Sindbis virus infection (Fig. 7D). The levels of viral transcripts were virtually undetectable in mock-infected animals, as expected. Following infection, the levels of nSP1 and SINV E1 were significantly higher in the snoRNA:U3:9B knockout strains than in the wild-type or control snoRNA deletion. The significant reduction of pupation frequencies and increased viral replication observed in snoRNA:U3:9B knockout larvae demonstrated that snoRNA:U3:9B is specifically required for efficient antiviral defence in vivo.

Figure 7.

Figure 7.

Knockout of snoRNA:U3:9B leads to reduced survival rates following a viral challenge. (A) Bright field images of representative wild-type (ActGAL4 > SIN) and snoRNA:U3:9B knock out (Δ9B1; ActGAL4 > SIN and Δ9B3; ActGAL4 > SIN) larvae expressing the SIN replicon under the control of the ActGAL4 driver. (B) Bar plot showing the percentage of larvae pupating in a control line (ActGAL4 > SIN) and two snoRNA:U3:9B deletion lines (Δ9B1; ActGAL4 > SIN and Δ9B3; ActGAL4 > SIN). Multiple comparisons were carried out using ordinary one-way ANOVA combined with a two-stage step-up procedure of Benjamini, Krieger, and Yekutieli. Adjusted P-values are shown in the figure. N = 3 with 50 animals in each replicate and group. (C) Bar plot showing the percentage of larvae pupating in a control line (w1118), control snoRNA deletion line (ΔA2486) and two snoRNA:U3:9B deletion lines (Δ9B1 and Δ9B3), either mock infected or infected with a Sindbis virus. Multiple comparisons were carried out using two-way ANOVA combined with a two-stage linear step-up procedure of Benjamini, Krieger, and Yekutieli. Adjusted P-values are shown. N = 7 independent experiments, each with 50 animals injected for each genotype. (D) Bar plot showing the relative levels of two viral transcripts, nSP1 and SINV E1, in larval brains of third instar larvae in a control line (w1118), control snoRNA deletion line (ΔA2486), and two snoRNA:U3:9B deletion lines (Δ9B1 and Δ9B3), either mock infected or infected with a Sindbis virus. Multiple comparisons were carried out using two-way ANOVA combined with a two-stage linear step-up procedure of Benjamini, Krieger, and Yekutieli. Adjusted P-values are shown. N = 3.

Discussion

RNA has long been recognized as an abundant component of the chromatin [96] and robust evidence underscores the important roles of many ncRNAs in regulating gene expression and shaping genome organization [97]. SnoRNAs have been shown to be particularly enriched in the chromatin of both insect and mammalian cells [3, 33, 56, 98]. Additionally, genome-wide mapping of RNA–DNA interactions using ChAR-seq has identified a significant association between numerous snoRNAs, including snoRNA:U3:9B, and protein-coding genes in the chromatin of D. melanogaster [3]. These findings suggested that snoRNAs may play a dedicated role in the regulation of gene expression. Here, we demonstrate that the snoRNA:U3:9B is upregulated in response to viral infections, plays a crucial role in the activation of immune response genes, and is required for survival during viral infection.

Viruses often hijack the cellular machineries to support their own replication and transcription, and a plethora of mechanisms have been discovered by which ncRNAs become repurposed upon viral infection. A gene-trap insertional mutagenesis study carried out in five mammalian cell lines using a battery of 12 different viruses identified as many as 83 snoRNAs that were required for efficient viral infectivity [99]. Not only snoRNAs, but also miRNAs and lncRNAs have been shown to promote viral replication or suppress the cellular immune response through a variety of molecular mechanisms [42, 100]. Moreover, snoRNA upregulation in response to viral infections is a relatively common phenomenon [101, 102] and thus the fact that snoRNA:U3:9B is upregulated in the Sindbis model is not unexpected. The novelty of our current findings lies instead in the identification of snoRNA:U3:9B as a critical component of the antiviral response.

We have made use of an already established model for studies of Sindbis replication in Drosophila based on the GAL4-induced expression of a viral replicon integrated in the Drosophila genome [72]. In this model, the structural capsid proteins are not synthesized, which precludes virion production and the spreading of a systemic infection. However, the expression of the viral nonstructural proteins is efficiently induced and the host gene expression is changed in ways that mimic to a remarkable extent the gene expression changes occurring in a bona-fide viral infection. These antiviral responses include not only RNAi, but also activation of specific antimicrobial pathways and induction of immune response genes, as initially shown by Avadhanula et al. [72]. Most of our present conclusions are derived from studies in which we used this SIN replicon model. However, we have also demonstrated the antiviral role of snoRNA:U3:9B in infection experiments using a wild-type, fully-infective strain of Sindbis virus, which reinforces the physiological significance of snoRNA:U3:9B in antiviral defence.

Canonical C/D box snoRNAs are associated with a set of snoRNA-binding proteins that typically includes the 2′-O-methyltransferase Fibrillarin. Our FISH experiments showed a broad distribution of U3 snoRNAs in salivary gland polytene chromosomes, but failed to reveal a similarly widespread distribution for Fibrillarin. Technical artifacts related to epitope masking are unlikely because the antibody that was used in our experiments was polyclonal. Thus, we favor the interpretation that snoRNA:U3:9B is part of a noncanonical snoRNP complex that lacks Fibrillarin. Several mechanisms have been reported by which snoRNAs facilitate gene expression in chromatin through noncanonical pathways [12103]. In mammalian cells, a set of snoRNAs interact with the mRNA 3′ processing complex and negatively regulate mRNA 3′ end formation co-transcriptionally by blocking the interaction between the cleavage and polyadenylation specificity factor and the polyadenylation signal in the nascent pre-mRNA [26]. SnoRNAs can also regulate pre-mRNA splicing through RNA–RNA interactions [28]. Furthermore, snoRNAs have been suggested to facilitate the establishment of open chromatin states by binding to histone tails via a tripartite interaction that involves the chromatin decondensation factor Df31 [33].

Our present findings are compatible with a model in which snoRNA:U3:9B is targeted to specific genes through RNA:RNA interactions and acts locally to promote an open chromatin conformation that is required for efficient gene activation. Pull-down experiments using antisense oligonucleotide probes revealed a physical association between the snoRNA:U3:9B and target immune response genes in the absence of an immune challenge, albeit at relatively low levels. Notably, this association was significantly enhanced in the context of viral replication. We have not formally investigated whether this increased association is directly related to the increased abundance of snoRNA:U3:9B in cells that support Sindbis replication or is caused by a specific targeting mechanism. The fact that not all the analyzed target genes show the same increase suggests that the association between the snoRNA:U3:9B and a specific subset of target genes relies on dedicated targeting mechanisms that operate in response to infection. Such targeting mechanisms are likely to involve specific interactions and the significant enrichment of snoRNA:U3:9B binding sites. The use of a computational tool for prediction of snoRNA targets identified a high number of potential hits for snoRNA:U3:9B, and we identified RNA sequence motifs enriched in the immune target transcripts that were predicted to interact with snoRNA:U3:9B. Based on these observations, we envision that direct RNA:RNA interactions between snoRNA:U3:9B and nascent transcripts could enhance the association of the snoRNA with activated immune response genes early during gene activation.

Viral infections induce the expression of a large number of genes that are regulated through different signaling pathways [44, 48, 49]. The details of such regulation are far from being fully understood and are, to a certain extent, specific for different types of viruses. While specific transcription factors that play pivotal roles in mediating the transcriptional response to immune challenges have been identified and extensively studied [48, 53, 55], the mechanisms by which chromatin regulation shapes the immune transcriptional responses remain less understood. Our current findings reveal that infection with the Sindbis virus induces significant alterations in chromatin accessibility at specific genomic loci. Furthermore, our results indicate that the activation of the antiviral response to Sindbis virus is more complex than previously recognized and involves a novel snoRNA that facilitates the recruitment of Brahma, the ATPase subunit of the SWI/SNF chromatin remodeling complex, to the promoters of specific genes. ChIRP and ChIP-qPCR experiments have shown the co-occupancy of snoRNA:U3:9B and Brahma within chromatin. The co-occupancy of snoRNA:U3:9B and Brahma was stronger in immune challenged conditions, and snoRNA:U3:9B was required for enhanced Brahma occupancy at genes that code for regulatory proteins such as the POU/homeodomain transcription factor Nubbin or the MAP kinase encoded by rolled (rl)/Erk. Our study does not distinguish between primary and secondary effects, and the intricate mechanisms by which snoRNA:U3:9B contributes to the sequence of events that govern chromatin dynamics during the antiviral response warrants further investigation. Interestingly, the human BRG1 protein -an ortholog of Drosophila Brahma- is an RNA-binding protein that interacts with U3 snoRNA [104]. This finding suggests that the involvement of specific snoRNAs in recruiting chromatin remodelers to activate transcription may be conserved across species.

Here we have investigated snoRNA:U3:9B and established its role in the activation of immune genes. Notably, two independent methodologies for genome-wide identification of snoRNA:U3:9B target genes -namely, an experimental approach utilizing ChAR-seq [3] and in silico analyses using target prediction tools [19]- have uncovered associations between snoRNA:U3:9B and thousands of genes in the D. melanogaster genome. In contrast to the widespread distribution of snoRNA:U3:9B across the genome, its deletion only had a modest effect on the transcriptome. A possible explanation for this apparent discrepancy is that snoRNA:U3:9B is part of a broad mechanism that helps maintain permissive chromatin states at many loci and is required for efficient gene activation in response to stimuli, but is not required for steady-state transcription. Interestingly, the association of snoRNA:U3:9B with protein-coding genes extends beyond genes related to immune responses, highlighting the broad regulatory potential of snoRNA:U3:9B. GO enrichment analyses of genes associated with snoRNA:U3:9B revealed consistent links to various signaling pathways, and this observation raises the intriguing possibility that snoRNAs may play a general role in enabling inducible chromatin states by facilitating the recruitment of ATP-dependent chromatin remodelers.

Supplementary Material

gkaf715_Supplemental_Files

Acknowledgements

We thank the Hardy lab (Indiana University Bloomington) for fly strains and the pUAST-SINrep:GFP plasmid, Jordan Rowley (University of Nebraska Medical Center) for the gift of the anti-Df31 antibody, and Ann Kristin Östlund Farrants (Stockholm University) for the gift of the anti-rat Brg1 antibody. We acknowledge support from the Swedish National Infrastructure for Computing/Uppsala Multidisciplinary Center for Advanced Computational Science for assistance with analysis of RNA-seq data and access to the UPPMAX computational infrastructure. We thank the Imaging Facility at Stockholm University (IFSU) for support with microscopy. We also thank BEA, the Bioinformatics and Expression Analysis core facility, which is supported by the board of research at the Karolinska Institute.

Author contributions: S.J. and N.V. conceptualized the project, coordinated the research activities, and wrote the manuscript. S.J. also performed experiments, validated results, and analyzed quantitative data. J.P. and I.S. processed next-generation sequencing data and performed bioinformatics analyses. I.R., D.B., and A.v.E. contributed to the investigation by performing fly genetics work, next-generation sequencing, and in situ hybridization, respectively. B.G.L. performed infection experiments and provided advice for statistical analyses. J.C.H. provided a Sindbis virus isolate. P.S. and N.O.G. provided the VSV-GFP. Y.E., M.M., and V.P. provided specialized knowledge in their respective areas of expertise and supervised parts of the work. All authors contributed to manuscript writing by providing comments on the manuscript draft.

Notes

Present address: Instituto de Biotecnología y Biomedicina (BiotecMed)/Departamento de Biología Celular, Universidad de Valencia, Valencia ES-46010, Spain

Present address: Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Solna SE-171 65, Sweden

Contributor Information

Shruti Jain, Department of Molecular Biosciences, Wenner-Gren Institute, Stockholm University, Stockholm SE-106 91, Sweden.

Jordi Planells, Department of Molecular Biosciences, Wenner-Gren Institute, Stockholm University, Stockholm SE-106 91, Sweden.

Isabel Regadas, Department of Molecular Biosciences, Wenner-Gren Institute, Stockholm University, Stockholm SE-106 91, Sweden.

Donal Barrett, SciLifeLab, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Solna SE-171 65, Sweden.

Anne von Euler, Department of Molecular Biosciences, Wenner-Gren Institute, Stockholm University, Stockholm SE-106 91, Sweden.

Indranil Sinha, Department of Molecular Biosciences, Wenner-Gren Institute, Stockholm University, Stockholm SE-106 91, Sweden.

Bo Gustav Lindberg, Department of Molecular Biosciences, Wenner-Gren Institute, Stockholm University, Stockholm SE-106 91, Sweden.

Jenny C Hesson, Department of Medical Biochemistry and Microbiology, Zoonosis Science Center, Uppsala University, Uppsala SE-751 23, Sweden.

Patrycja Swacha, Department of Molecular Biosciences, Wenner-Gren Institute, Stockholm University, Stockholm SE-106 91, Sweden.

Nelson O Gekara, Department of Molecular Biosciences, Wenner-Gren Institute, Stockholm University, Stockholm SE-106 91, Sweden.

Vicent Pelechano, SciLifeLab, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Solna SE-171 65, Sweden.

Ylva Engström, Department of Molecular Biosciences, Wenner-Gren Institute, Stockholm University, Stockholm SE-106 91, Sweden.

Mattias Mannervik, Department of Molecular Biosciences, Wenner-Gren Institute, Stockholm University, Stockholm SE-106 91, Sweden.

Neus Visa, Department of Molecular Biosciences, Wenner-Gren Institute, Stockholm University, Stockholm SE-106 91, Sweden.

Supplementary data

Supplementary data is available at NAR online.

Conflict of interest

An earlier version of this manuscript is included in the doctoral thesis of Jordi Planells: http://www.diva-portal.org/smash/get/diva2:1796098/FULLTEXT01.pdf; https://su.diva-portal.org/smash/record.jsf?faces-redirect=true&aq2=%5B%5B%5D%5D&af=%5B%5D&searchType=SIMPLE&sortOrder2=title_sort_asc&query=&language=sv&pid=diva2%3A1796080&aq=%5B%5B%5D%5D&sf=all&aqe=%5B%5D&sortOrder=author_sort_asc&onlyFullText=false&noOfRows=50&dswid=-7995.

Funding

The project was funded with a grant from the Swedish Research Council (2019-02335). V.P. acknowledges funding from the Swedish Research Council (2020-01480 and 2021-06112), a Wallenberg Academy Fellowship (KAW 2021.0167), and Karolinska Institute. Y.E. acknowledges funding from the Swedish Research Council (2024-04173) and The Swedish Cancer Society (20 1044 Pj and 23 2963 Pj). N.O.G. acknowledges funding from the Swedish Research Council (2022-01308_3) and The Swedish Cancer Society (CAN 23 3096 Pj). S.J. was partially supported by SFO funding from the Faculty of Science at the Stockholm University and J.P.R. was supported by the Department of Molecular Biosciences, Wenner-Gren Institute, Stockholm University. Funding to pay the Open Access publication charges for this article was provided by Stockholm University.

Data availability

The RNA-seq and ATAC-seq data produced in this study are available from NCBI Gene Expression Omnibus (GEO accession GSE281912).

References

  • 1. Li  X, Fu  X-D  Chromatin-associated RNAs as facilitators of functional genomic interactions. Nat Rev Genet. 2019; 20:503–19. 10.1038/s41576-019-0135-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Sridhar  B, Rivas-Astroza  M, Nguyen  TC  et al.  Systematic mapping of RNA-chromatin interactions In Vivo. Curr Biol. 2017; 27:602–9. 10.1016/j.cub.2017.01.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Bell  JC, Jukam  D, Teran  NA  et al.  Chromatin-associated RNA sequencing (ChAR-seq) maps genome-wide RNA-to-DNA contacts. eLife. 2018; 7:e27024. 10.7554/eLife.27024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Zhou  B, Li  X, Luo  D  et al.  GRID-seq for comprehensive analysis of global RNA–chromatin interactions. Nat Protoc. 2019; 14:2036–68. 10.1038/s41596-019-0172-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Wu  W, Yan  Z, Nguyen  TC  et al.  Mapping RNA–chromatin interactions by sequencing with iMARGI. Nat Protoc. 2019; 14:3243–72. 10.1038/s41596-019-0229-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Bonetti  A, Agostini  F, Suzuki  AM  et al.  RADICL-seq identifies general and cell type–specific principles of genome-wide RNA-chromatin interactions. Nat Commun. 2020; 11:1018. 10.1038/s41467-020-14337-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Dupuis-Sandoval  F, Poirier  M, Scott  MS  The emerging landscape of small nucleolar RNAs in cell biology. Wiley Interdiscip Rev RNA. 2015; 6:381–97. 10.1002/wrna.1284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Sriram  K, Luo  Y, Malhi  NK  et al.  Methods to study RNA–chromatin interactions. Methods Mol Biol. 2023; 2666:279–97. [DOI] [PubMed] [Google Scholar]
  • 9. Lafontaine  DLJ, Tollervey  D  Birth of the snoRNPs: the evolution of the modification-guide snoRNAs. Trends Biochem Sci. 1998; 23:383–8. 10.1016/S0968-0004(98)01260-2. [DOI] [PubMed] [Google Scholar]
  • 10. Maxwell  ES, Fournier  MJ  The small nucleolar RNAs. Annu Rev Biochem. 1995; 64:897–934. 10.1146/annurev.bi.64.070195.004341. [DOI] [PubMed] [Google Scholar]
  • 11. Kiss  T  Small nucleolar RNAs: an abundant group of noncoding RNAs with diverse cellular functions. Cell. 2002; 109:145–8. 10.1016/S0092-8674(02)00718-3. [DOI] [PubMed] [Google Scholar]
  • 12. Bratkovič  T, Božič  J, Rogelj  B  Functional diversity of small nucleolar RNAs. Nucleic Acids Res. 2020; 48:1627–51. 10.1093/nar/gkz1140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Lu  Z, Zhang  QC, Lee  B  et al.  RNA duplex map in living cells reveals higher-order transcriptome structure. Cell. 2016; 165:1267–79. 10.1016/j.cell.2016.04.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Aw  JGA, Shen  Y, Wilm  A  et al.  In vivo mapping of eukaryotic RNA interactomes reveals principles of higher-order organization and regulation. Mol Cell. 2016; 62:603–17. 10.1016/j.molcel.2016.04.028. [DOI] [PubMed] [Google Scholar]
  • 15. Ziv  O, Gabryelska  MM, Lun  ATL  et al.  COMRADES determines in vivo RNA structures and interactions. Nat Methods. 2018; 15:785–8. 10.1038/s41592-018-0121-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Cai  Z, Cao  C, Ji  L  et al.  RIC-seq for global in situ profiling of RNA–RNA spatial interactions. Nature. 2020; 582:432–7. 10.1038/s41586-020-2249-1. [DOI] [PubMed] [Google Scholar]
  • 17. Tafer  H, Kehr  S, Hertel  J  et al.  RNAsnoop: efficient target prediction for H/ACA snoRNAs. Bioinformatics. 2010; 26:610–6. 10.1093/bioinformatics/btp680. [DOI] [PubMed] [Google Scholar]
  • 18. Kehr  S, Bartschat  S, Stadler  PF  et al.  PLEXY: efficient target prediction for box C/D snoRNAs. Bioinformatics. 2011; 27:279–80. 10.1093/bioinformatics/btq642. [DOI] [PubMed] [Google Scholar]
  • 19. Deschamps-Francoeur  G, Couture  S, Abou-Elela  S  et al.  The snoGloBe interaction predictor reveals a broad spectrum of C/D snoRNA RNA targets. Nucleic Acids Res. 2022; 50:6067–83. 10.1093/nar/gkac475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Huang  Z-P, Zhou  H, He  H-L  et al.  Genome-wide analyses of two families of snoRNA genes from Drosophila melanogaster, demonstrating the extensive utilization of introns for coding of snoRNAs. RNA. 2005; 11:1303–16. 10.1261/rna.2380905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Jorjani  H, Kehr  S, Jedlinski  DJ  et al.  An updated human snoRNAome. Nucleic Acids Res. 2016; 44:5068–82. 10.1093/nar/gkw386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Jády  BE, Darzacq  X, Tucker  KE  et al.  Modification of Sm small nuclear RNAs occurs in the nucleoplasmic Cajal body following import from the cytoplasm. EMBO J. 2003; 22:1878–88. 10.1093/emboj/cdg187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Vitali  P, Kiss  T  Cooperative 2′-O-methylation of the wobble cytidine of human elongator tRNAMet(CAT) by a nucleolar and a Cajal body-specific box C/D RNP. Genes Dev. 2019; 33:741–6. 10.1101/gad.326363.119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Elliott  BA, Ho  H-T, Ranganathan  SV  et al.  Modification of messenger RNA by 2′-O-methylation regulates gene expression in vivo. Nat Commun. 2019; 10:3401. 10.1038/s41467-019-11375-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Kass  S, Tyc  K, Steitz  JA  et al.  The U3 small nucleolar ribonucleoprotein functions in the first step of preribosomal RNA processing. Cell. 1990; 60:897–908. 10.1016/0092-8674(90)90338-F. [DOI] [PubMed] [Google Scholar]
  • 26. Huang  C, Shi  J, Guo  Y  et al.  A snoRNA modulates mRNA 3′ end processing and regulates the expression of a subset of mRNAs. Nucleic Acids Res. 2017; 45:8647–60. 10.1093/nar/gkx651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Garus  A, Autexier  C  Dyskerin: an essential pseudouridine synthase with multifaceted roles in ribosome biogenesis, splicing, and telomere maintenance. RNA. 2021; 27:1441–58. 10.1261/rna.078953.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Bergeron  D, Faucher-Giguère  L, Emmerichs  A-K  et al.  Intronic small nucleolar RNAs regulate host gene splicing through base pairing with their adjacent intronic sequences. Genome Biol. 2023; 24:160. 10.1186/s13059-023-03002-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Jiang  Y, Sun  S, Liu  X  et al.  U3 snoRNA inter-regulates with DDX21 in the perichromosomal region to control mitosis. Cell Death Dis. 2024; 15:342. 10.1038/s41419-024-06725-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Ender  C, Krek  A, Friedländer  MR  et al.  A human snoRNA with MicroRNA-like functions. Mol Cell. 2008; 32:519–28. 10.1016/j.molcel.2008.10.017. [DOI] [PubMed] [Google Scholar]
  • 31. Kim  D-S, Camacho  CV, Nagari  A  et al.  Activation of PARP-1 by snoRNAs controls ribosome biogenesis and cell growth via the RNA helicase DDX21. Mol Cell. 2019; 75:1270–85. 10.1016/j.molcel.2019.06.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Bergstrand  S, O’Brien  EM, Coucoravas  C  et al.  Small Cajal body-associated RNA 2 (scaRNA2) regulates DNA repair pathway choice by inhibiting DNA-PK. Nat Commun. 2022; 13:1015. 10.1038/s41467-022-28646-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Schubert  T, Pusch  MC, Diermeier  S  et al.  Df31 protein and snoRNAs maintain accessible higher-order structures of chromatin. Mol Cell. 2012; 48:434–44. 10.1016/j.molcel.2012.08.021. [DOI] [PubMed] [Google Scholar]
  • 34. Sahoo  T, del Gaudio  D, German  JR  et al.  Prader–Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster. Nat Genet. 2008; 40:719–21. 10.1038/ng.158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Fontana  P, Grasso  M, Acquaviva  F  et al.  SNORD116 deletions cause Prader–Willi syndrome with a mild phenotype and macrocephaly. Clin Genet. 2017; 92:440–3. 10.1111/cge.13005. [DOI] [PubMed] [Google Scholar]
  • 36. Jenkinson  EM, Rodero  MP, Kasher  PR  et al.  Mutations in SNORD118 cause the cerebral microangiopathy leukoencephalopathy with calcifications and cysts. Nat Genet. 2016; 48:1185–92. 10.1038/ng.3661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Dong  X-Y, Guo  P, Boyd  J  et al.  Implication of snoRNA U50 in human breast cancer. J Genet Genom. 2009; 36:447–54. 10.1016/S1673-8527(08)60134-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Herter  EK, Stauch  M, Gallant  M  et al.  snoRNAs are a novel class of biologically relevant Myc targets. BMC Biol. 2015; 13:25. 10.1186/s12915-015-0132-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Xu  B, Ye  M-H, Lv  S-G  et al.  SNORD47, a box C/D snoRNA, suppresses tumorigenesis in glioblastoma. Oncotarget. 2017; 8:43953–66. 10.18632/oncotarget.16693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Pauli  C, Liu  Y, Rohde  C  et al.  Site-specific methylation of 18S ribosomal RNA by SNORD42A is required for acute myeloid leukemia cell proliferation. Blood. 2020; 135:2059–70. 10.1182/blood.2019004121. [DOI] [PubMed] [Google Scholar]
  • 41. Liu  X, Ali  MK, Zhao  L  et al.  The emerging diagnostic and therapeutic roles of small nucleolar RNAs in lung diseases. Biomed Pharmacother. 2023; 161:114519. [DOI] [PubMed] [Google Scholar]
  • 42. Stamm  S, Lodmell  JS  C/D box snoRNAs in viral infections: RNA viruses use old dogs for new tricks. Noncoding RNA Res. 2019; 4:46–53. 10.1016/j.ncrna.2019.02.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Hoffmann  JA  The immune response of Drosophila. Nature. 2003; 426:33–8. 10.1038/nature02021. [DOI] [PubMed] [Google Scholar]
  • 44. Sabin  LR, Hanna  SL, Cherry  S  Innate antiviral immunity in Drosophila. Curr Opin Immunol. 2010; 22:4–9. 10.1016/j.coi.2010.01.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Kemp  C, Mueller  S, Goto  A  et al.  Broad RNA interference–mediated antiviral immunity and virus-specific inducible responses in drosophila. J Immunol. 2013; 190:650–8. 10.4049/jimmunol.1102486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Bonning  BC, Saleh  M-C  The interplay between viruses and RNAi pathways in insects. Annu Rev Entomol. 2021; 66:61–79. 10.1146/annurev-ento-033020-090410. [DOI] [PubMed] [Google Scholar]
  • 47. Deddouche  S, Matt  N, Budd  A  et al.  The DExD/H-box helicase dicer-2 mediates the induction of antiviral activity in drosophila. Nat Immunol. 2008; 9:1425–32. 10.1038/ni.1664. [DOI] [PubMed] [Google Scholar]
  • 48. Yu  S, Luo  F, Xu  Y  et al.  Drosophila innate immunity involves multiple signaling pathways and coordinated communication between different tissues. Front Immunol. 2022; 13:905370. 10.3389/fimmu.2022.905370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Yang  Y, Zhou  H, Huang  X  et al.  Innate immune and proinflammatory signals activate the Hippo pathway via a Tak1-STRIPAK-Tao axis. Nat Commun. 2024; 15:145. 10.1038/s41467-023-44542-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Hanson  MA, Lemaitre  B  New insights on Drosophila antimicrobial peptide function in host defense and beyond. Curr Opin Immunol. 2020; 62:22–30. 10.1016/j.coi.2019.11.008. [DOI] [PubMed] [Google Scholar]
  • 51. Costa  A, Jan  E, Sarnow  P  et al.  The Imd pathway is involved in antiviral immune responses in Drosophila. PLoS One. 2009; 4:e7436. 10.1371/journal.pone.0007436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Valanne  S, Vesala  L, Maasdorp  MK  et al.  The Drosophila toll pathway in Innate immunity: from the core pathway toward effector functions. J Immunol. 2022; 209:1817–25. 10.4049/jimmunol.2200476. [DOI] [PubMed] [Google Scholar]
  • 53. Liu  B, Zheng  Y, Yin  F  et al.  Toll receptor-mediated hippo signaling controls innate immunity in Drosophila. Cell. 2016; 164:406–19. 10.1016/j.cell.2015.12.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Tafesh-Edwards  G, Eleftherianos  I  JNK signaling in Drosophila immunity and homeostasis. Immunol Lett. 2020; 226:7–11. 10.1016/j.imlet.2020.06.017. [DOI] [PubMed] [Google Scholar]
  • 55. Mongelli  V, Lequime  S, Kousathanas  A  et al.  Innate immune pathways act synergistically to constrain RNA virus evolution in Drosophila melanogaster. Nat Ecol Evol. 2022; 6:565–78. 10.1038/s41559-022-01697-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Planells  J, Jordán-Pla  A, Jain  S  et al.  The exosome degrades chromatin-associated RNAs genome-wide and maintains chromatin homeostasis. bioRxiv10 April 2023, preprint: not peer reviewed 10.1101/2023.04.10.536209. [DOI]
  • 57. Phipps  KR, Charette  JM, Baserga  SJ  The small subunit processome in ribosome biogenesis—progress and prospects. Wiley Interdiscip Rev RNA. 2011; 2:1–21. 10.1002/wrna.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Cavalcante  RG, Sartor  MA  annotatr: genomic regions in context. Bioinformatics. 2017; 33:2381–3. 10.1093/bioinformatics/btx183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Ge  SX, Jung  D, Yao  R  ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics. 2020; 36:2628–9. 10.1093/bioinformatics/btz931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Grant  CE, Bailey  TL  XSTREME: comprehensive motif analysis of biological sequence datasets. bioRxiv3 September 2021, preprint: not peer reviewed 10.1101/2021.09.02.458722. [DOI]
  • 61. Bailey  TL  STREME: accurate and versatile sequence motif discovery. Bioinformatics. 2021; 37:2834–40. 10.1093/bioinformatics/btab203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. Hesson  JC, Verner-Carlsson  J, Larsson  A  et al.  Culex torrentium mosquito role as major enzootic vector defined by rate of Sindbis virus infection, Sweden, 2009. Emerg Infect Dis. 2015; 21:875–8. 10.3201/eid2105.141577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63. Erttmann  SF, Swacha  P, Aung  KM  et al.  The gut microbiota prime systemic antiviral immunity via the cGAS-STING-IFN-I axis. Immunity. 2022; 55:847–61. 10.1016/j.immuni.2022.04.006. [DOI] [PubMed] [Google Scholar]
  • 64. Port  F, Chen  H-M, Lee  T  et al.  Optimized CRISPR/Cas tools for efficient germline and somatic genome engineering in Drosophila. Proc Natl Acad Sci USA. 2014; 111:E2967–76. 10.1073/pnas.1405500111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65. Patel  H, Ewels  P, Manning  J  et al.  nf-core/rnaseq: nf-core/rnaseq v3.17.0 - Neon Newt. 10.5281/ZENODO.1400710. 2024; [Google Scholar]
  • 66. Di  Tommaso P, Chatzou  M, Floden  EW  et al.  Nextflow enables reproducible computational workflows. Nat Biotechnol. 2017; 35:316–9. 10.1038/nbt.3820. [DOI] [PubMed] [Google Scholar]
  • 67. Love  MI, Huber  W, Anders  S  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014; 15:550. 10.1186/s13059-014-0550-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68. Buenrostro  JD, Giresi  PG, Zaba  LC  et al.  Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat Methods. 2013; 10:1213–8. 10.1038/nmeth.2688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69. Dhall  JK, Kasturacharya  N, Pandit  A  et al.  Optimized protocol for assay for transposase-accessible chromatin by sequencing (ATAC-seq) from Drosophila melanogaster brain tissue. STAR Protoc. 2023; 4:102153. 10.1016/j.xpro.2023.102153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70. Amemiya  HM, Kundaje  A, Boyle  AP  The ENCODE blacklist: identification of problematic regions of the genome. Sci Rep. 2019; 9:9354. 10.1038/s41598-019-45839-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71. Lun  ATL, Smyth  GK  csaw: a bioconductor package for differential binding analysis of ChIP-seq data using sliding windows. Nucleic Acids Res. 2016; 44:e45. 10.1093/nar/gkv1191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72. Avadhanula  V, Weasner  BP, Hardy  GG  et al.  A novel system for the launch of alphavirus RNA synthesis reveals a role for the imd pathway in arthropod antiviral response. PLoS Pathog. 2009; 5:e1000582. 10.1371/journal.ppat.1000582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73. Ni  J-Q, Zhou  R, Czech  B  et al.  A genome-scale shRNA resource for transgenic RNAi in Drosophila. Nat Methods. 2011; 8:405–7. 10.1038/nmeth.1592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74. Chu  C, Qu  K, Zhong  FL  et al.  Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions. Mol Cell. 2011; 44:667–78. 10.1016/j.molcel.2011.08.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75. Botelho  SC, Tyagi  A, Hessle  V  et al.  The association of Brahma with the Balbiani ring 1 gene of Chironomus tentans studied by immunoelectron microscopy and chromatin immunoprecipitation. Insect Mol Biol. 2008; 17:505–13. 10.1111/j.1365-2583.2008.00825.x. [DOI] [PubMed] [Google Scholar]
  • 76. Ostlund  Farrants AK, Blomquist  P, Kwon  H  et al.  Glucocorticoid receptor-glucocorticoid response element binding stimulates nucleosome disruption by the SWI/SNF complex. Mol Cell Biol. 1997; 17:895–905. 10.1128/MCB.17.2.895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77. Filion  GJ, Van Bemmel  JG, Braunschweig  U  et al.  Systematic protein location mapping reveals five principal chromatin types in drosophila cells. Cell. 2010; 143:212–24. 10.1016/j.cell.2010.09.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78. Brown  JB, Boley  N, Eisman  R  et al.  Diversity and dynamics of the Drosophila transcriptome. Nature. 2014; 512:393–9. 10.1038/nature12962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79. Rämet  M, Manfruelli  P, Pearson  A  et al.  Functional genomic analysis of phagocytosis and identification of a drosophila receptor for E. coli. Nature. 2002; 416:644–8. 10.1038/nature735. [DOI] [PubMed] [Google Scholar]
  • 80. Kleino  A, Valanne  S, Ulvila  J  et al.  Inhibitor of apoptosis 2 and TAK1-binding protein are components of the Drosophila Imd pathway. EMBO J. 2005; 24:3423–34. 10.1038/sj.emboj.7600807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81. Griffin  DE  Alphavirus encephalomyelitis: mechanisms and approaches to prevention of neuronal damage. Neurotherapeutics. 2016; 13:455–60. 10.1007/s13311-016-0434-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82. Tzou  P, Ohresser  S, Ferrandon  D  et al.  Tissue-specific inducible expression of antimicrobial peptide genes in drosophila surface epithelia. Immunity. 2000; 13:737–48. 10.1016/S1074-7613(00)00072-8. [DOI] [PubMed] [Google Scholar]
  • 83. Huang  Z, Kingsolver  MB, Avadhanula  V  et al.  An antiviral role for antimicrobial peptides during the arthropod response to alphavirus replication. J Virol. 2013; 87:4272–80. 10.1128/JVI.03360-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84. Mudiganti  U, Hernandez  R, Brown  DT  Insect response to alphavirus infection—establishment of alphavirus persistence in insect cells involves inhibition of viral polyprotein cleavage. Virus Res. 2010; 150:73–84. 10.1016/j.virusres.2010.02.016. [DOI] [PubMed] [Google Scholar]
  • 85. Nakano  S, Kashio  S, Nishimura  K  et al.  Damage sensing mediated by serine proteases Hayan and Persephone for toll pathway activation in apoptosis-deficient flies. PLoS Genet. 2023; 19:e1010761. 10.1371/journal.pgen.1010761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86. Shen  R, Zheng  K, Zhou  Y  et al.  A dRASSF-STRIPAK-imd-JAK/STAT axis controls antiviral immune response in Drosophila. Cell Rep. 2022; 40:111143. 10.1016/j.celrep.2022.111143. [DOI] [PubMed] [Google Scholar]
  • 87. Ip  YT, Reach  M, Engstrom  Y  et al.  Dif, a dorsal-related gene that mediates an immune response in Drosophila. Cell. 1993; 75:753–63. 10.1016/0092-8674(93)90495-C. [DOI] [PubMed] [Google Scholar]
  • 88. Nakamoto  M, Moy  RH, Xu  J  et al.  Virus recognition by toll-7 activates antiviral autophagy in Drosophila. Immunity. 2012; 36:658–67. 10.1016/j.immuni.2012.03.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89. Gatchalian  J, Liao  J, Maxwell  MB  et al.  Control of stimulus-dependent responses in macrophages by SWI/SNF chromatin remodeling complexes. Trends Immunol. 2020; 41:126–40. 10.1016/j.it.2019.12.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90. Bonnay  F, Nguyen  X, Cohen-Berros  E  et al.  Akirin specifies NF-κb selectivity of Drosophila innate immune response via chromatin remodeling. EMBO J. 2014; 33:2349–62. 10.15252/embj.201488456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91. Liu  X, Lu  Y, Zhu  J  et al.  A long noncoding RNA, antisense IL-7, promotes inflammatory gene transcription through facilitating histone acetylation and switch/sucrose nonfermentable chromatin remodeling. J Immunol. 2019; 203:1548–59. 10.4049/jimmunol.1900256. [DOI] [PubMed] [Google Scholar]
  • 92. Tyagi  A, Ryme  J, Brodin  D  et al.  SWI/SNF associates with Nascent pre-mRNPs and regulates alternative pre-mRNA processing. PLoS Genet. 2009; 5:e1000470. 10.1371/journal.pgen.1000470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93. Grossi  E, Raimondi  I, Goñi  E  et al.  A lncRNA-SWI/SNF complex crosstalk controls transcriptional activation at specific promoter regions. Nat Commun. 2020; 11:936. 10.1038/s41467-020-14623-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94. Xu  J, Hopkins  K, Sabin  L  et al.  ERK signaling couples nutrient status to antiviral defense in the insect gut. Proc Natl Acad Sci USA. 2013; 110:15025–30. 10.1073/pnas.1303193110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95. Lindberg  BG, Tang  X, Dantoft  W  et al.  Nubbin isoform antagonism governs Drosophila intestinal immune homeostasis. PLoS Pathog. 2018; 14:e1006936. 10.1371/journal.ppat.1006936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96. Nickerson  JA, Krochmalnic  G, Wan  KM  et al.  Chromatin architecture and nuclear RNA. Proc Natl Acad Sci USA. 1989; 86:177–81. 10.1073/pnas.86.1.177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97. Mangiavacchi  A, Morelli  G, Orlando  V  Behind the scenes: how RNA orchestrates the epigenetic regulation of gene expression. Front Cell Dev Biol. 2023; 11:1123975. 10.3389/fcell.2023.1123975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98. Shen  W, Zhang  Y, Shi  M  et al.  Profiling and characterization of constitutive chromatin-enriched RNAs. iScience. 2022; 25:105349. 10.1016/j.isci.2022.105349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99. Murray  JL, Sheng  J, Rubin  DH  A role for H/ACA and C/D small nucleolar RNAs in viral replication. Mol Biotechnol. 2014; 56:429–37. 10.1007/s12033-013-9730-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100. Behnia  M, Bradfute  SB  The host non-coding RNA response to alphavirus infection. Viruses. 2023; 15:562. 10.3390/v15020562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101. Hutzinger  R, Feederle  R, Mrazek  J  et al.  Expression and processing of a small nucleolar RNA from the Epstein–Barr Virus genome. PLoS Pathog. 2009; 5:e1000547. 10.1371/journal.ppat.1000547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102. Saxena  T, Tandon  B, Sharma  S  et al.  Combined miRNA and mRNA signature identifies key molecular players and pathways involved in Chikungunya virus infection in Human cells. PLoS One. 2013; 8:e79886. 10.1371/journal.pone.0079886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103. Falaleeva  M, Welden  JR, Duncan  MJ  et al.  C/D-box snoRNAs form methylating and non-methylating ribonucleoprotein complexes: old dogs show new tricks. Bioessays. 2017; 39:1600264. 10.1002/bies.201600264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104. Oo  JA, Warwick  T, Pálfi  K  et al.  Long non-coding RNAs direct the SWI/SNF complex to cell type-specific enhancers. Nat Commun. 2025; 16:131. 10.1038/s41467-024-55539-6. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

gkaf715_Supplemental_Files

Data Availability Statement

The RNA-seq and ATAC-seq data produced in this study are available from NCBI Gene Expression Omnibus (GEO accession GSE281912).


Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES